LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MCF7 | Erlotinib | 3.33 | uM | LJP5 | 1 | M20 | 72 | hr | 1389 | 6419 | 5772 | 1.1120 | 1.1060 |
| MCF7 | Erlotinib | 3.33 | uM | LJP5 | 3 | M20 | 72 | hr | 1389 | 6431 | 6038 | 1.0650 | 1.0603 |
| MCF7 | Erlotinib | 10 | uM | LJP5 | 1 | M19 | 72 | hr | 1389 | 5296 | 5772 | 0.9175 | 0.9179 |
| MCF7 | Erlotinib | 10 | uM | LJP5 | 3 | M19 | 72 | hr | 1389 | 5658 | 6038 | 0.9370 | 0.9395 |
| MCF7 | Gefitinib | 0.04 | uM | LJP6 | 1 | N12 | 72 | hr | 1389 | 5694 | 5147 | 1.1063 | 1.1098 |
| MCF7 | Gefitinib | 0.04 | uM | LJP6 | 2 | N12 | 72 | hr | 1389 | 5818 | 5447 | 1.0679 | 1.0678 |
| MCF7 | Gefitinib | 0.04 | uM | LJP6 | 3 | N12 | 72 | hr | 1389 | 6253 | 5740 | 1.0893 | 1.0853 |
| MCF7 | Gefitinib | 0.12 | uM | LJP6 | 1 | N11 | 72 | hr | 1389 | 5179 | 5147 | 1.0062 | 1.0066 |
| MCF7 | Gefitinib | 0.12 | uM | LJP6 | 2 | N11 | 72 | hr | 1389 | 5715 | 5447 | 1.0490 | 1.0491 |
| MCF7 | Gefitinib | 0.12 | uM | LJP6 | 3 | N11 | 72 | hr | 1389 | 6435 | 5740 | 1.1210 | 1.1148 |
| MCF7 | Gefitinib | 0.37 | uM | LJP6 | 1 | N10 | 72 | hr | 1389 | 5377 | 5147 | 1.0447 | 1.0468 |
| MCF7 | Gefitinib | 0.37 | uM | LJP6 | 2 | N10 | 72 | hr | 1389 | 5843 | 5447 | 1.0725 | 1.0723 |
| MCF7 | Gefitinib | 0.37 | uM | LJP6 | 3 | N10 | 72 | hr | 1389 | 6129 | 5740 | 1.0677 | 1.0650 |
| MCF7 | Gefitinib | 1.11 | uM | LJP6 | 1 | N09 | 72 | hr | 1389 | 4761 | 5147 | 0.9250 | 0.9192 |
| MCF7 | Gefitinib | 1.11 | uM | LJP6 | 2 | N09 | 72 | hr | 1389 | 5301 | 5447 | 0.9730 | 0.9725 |
| MCF7 | Gefitinib | 1.11 | uM | LJP6 | 3 | N09 | 72 | hr | 1389 | 5844 | 5740 | 1.0180 | 1.0175 |
| MCF7 | Gefitinib | 3.33 | uM | LJP6 | 1 | N08 | 72 | hr | 1389 | 4917 | 5147 | 0.9553 | 0.9522 |
| MCF7 | Gefitinib | 3.33 | uM | LJP6 | 2 | N08 | 72 | hr | 1389 | 5566 | 5447 | 1.0217 | 1.0219 |
| MCF7 | Gefitinib | 3.33 | uM | LJP6 | 3 | N08 | 72 | hr | 1389 | 6027 | 5740 | 1.0499 | 1.0482 |
| MCF7 | Gefitinib | 10 | uM | LJP6 | 1 | N07 | 72 | hr | 1389 | 4072 | 5147 | 0.7911 | 0.7668 |
| MCF7 | Gefitinib | 10 | uM | LJP6 | 2 | N07 | 72 | hr | 1389 | 4903 | 5447 | 0.9000 | 0.8959 |
| MCF7 | Gefitinib | 10 | uM | LJP6 | 3 | N07 | 72 | hr | 1389 | 4987 | 5740 | 0.8687 | 0.8671 |
| MCF7 | Nilotinib | 0.04 | uM | LJP5 | 1 | N18 | 72 | hr | 1389 | 5546 | 5772 | 0.9608 | 0.9614 |
| MCF7 | Nilotinib | 0.04 | uM | LJP5 | 3 | N18 | 72 | hr | 1389 | 6654 | 6038 | 1.1019 | 1.0937 |
| MCF7 | Nilotinib | 0.12 | uM | LJP5 | 1 | N17 | 72 | hr | 1389 | 6306 | 5772 | 1.0924 | 1.0879 |